Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 7 results for author "Edward Mwarangu".

Back to authors

Thumbnail for Comparative Pharmacovigilance of CD20-Directed Bispecific Antibodies in B-Cell Lymphoma: A FAERS Observational Study

ABCL - 100

Comparative Pharmacovigilance of CD20-Directed Bispecific Antibodies in B-Cell Lymphoma: A FAERS Observational Study

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Have Survival Gains in Acute Myeloid Leukemia Been Equitable? Persistent Racial Disparities in a SEER Analysis (2000-2023)

AML - 085

Have Survival Gains in Acute Myeloid Leukemia Been Equitable? Persistent Racial Disparities in a SEER Analysis (2000-2023)

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Phenotype-Specific Safety Differences Between Gilteritinib and Midostaurin in AML: A FAERS Analysis Highlighting Differentiation Syndrome Signal

AML - 103

Phenotype-Specific Safety Differences Between Gilteritinib and Midostaurin in AML: A FAERS Analysis Highlighting Differentiation Syndrome Signal

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

CML - 115

Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Survival and Early Mortality Disparities in Classical Hodgkin Lymphoma Across the Immunotherapy Era: A SEER Analysis (2010-2022)

HL - 092

Survival and Early Mortality Disparities in Classical Hodgkin Lymphoma Across the Immunotherapy Era: A SEER Analysis (2010-2022)

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Target-Specific Toxicity Phenotypes of BCMA- vs GPRC5D-Directed Bispecific Antibodies in Multiple Myeloma: A FAERS Analysis

MM - 106

Target-Specific Toxicity Phenotypes of BCMA- vs GPRC5D-Directed Bispecific Antibodies in Multiple Myeloma: A FAERS Analysis

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Survival Outcomes and Racial Disparities in Adolescent and Young Adult Classic Philadelphia-Negative Myeloproliferative Neoplasms: A SEER Analysis, 2000-2023

MPN - 088

Survival Outcomes and Racial Disparities in Adolescent and Young Adult Classic Philadelphia-Negative Myeloproliferative Neoplasms: A SEER Analysis, 2000-2023

Edward Mwarangu

Poster Presenter: Edward Mwarangu

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.